{"product_id":"wc-0efe51bcb5f34c14-50424","title":"Harvard Update on Neurology and Psychiatry of Women 2025","description":"\u003ch1 data-pm-slice=\"1 1 []\"\u003eHarvard Update on Neurology and Psychiatry of Women 2025\u003c\/h1\u003e\r\n\u003ch2\u003eHarvard Update on Neurology and Psychiatry of Women 2025 | Women's Neurology, Reproductive Psychiatry, Migraine, Epilepsy, Pregnancy, Perinatal Mental Health, Hormonal Disorders \u0026amp; Alzheimer's Disease\u003c\/h2\u003e\r\nThe \u003cstrong\u003eHarvard Update on Neurology and Psychiatry of Women 2025\u003c\/strong\u003e provides a comprehensive, evidence-based educational review of neurological and psychiatric conditions affecting women throughout different stages of life.\r\n\r\nDeveloped by faculty from Harvard Medical School teaching hospitals and offered by \u003cstrong\u003eBrigham and Women's Hospital\u003c\/strong\u003e, this multidisciplinary continuing medical education program brings together experts in neurology, psychiatry, obstetrics, reproductive medicine, women's mental health, and primary care.\r\n\r\nHeld May 8–9, 2025, the two-day live online course explores the influence of biological sex, reproductive hormones, pregnancy, the postpartum period, and menopause on neurological and psychiatric health.\r\n\r\nThe program emphasizes sex-specific clinical assessment, individualized treatment strategies, reproductive safety, evidence-based management, and the application of current research to women's healthcare.\r\n\r\nImportant clinical areas include migraine, epilepsy, functional neurological disorders, autonomic dysfunction, contraception in patients with neurological or psychiatric conditions, bipolar disorder, psychosis during pregnancy, perinatal depression and anxiety, substance use disorders, hormonal mood changes, Alzheimer's disease, sexual health, and trauma-informed care.\r\n\r\nThe \u003cstrong\u003eHarvard Women's Neurology and Psychiatry 2025\u003c\/strong\u003e curriculum combines expert presentations, case-based discussions, interactive panels, and questions and answers to address complex clinical decisions affecting women across their lifespan.\r\n\u003ch2\u003eCourse Details\u003c\/h2\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eCourse:\u003c\/strong\u003e Harvard Update on Neurology and Psychiatry of Women 2025\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOfficial Program:\u003c\/strong\u003e Update on Neurology and Psychiatry of Women\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eAcademic Institution:\u003c\/strong\u003e Harvard Medical School\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOffered By:\u003c\/strong\u003e Brigham and Women's Hospital\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eDates:\u003c\/strong\u003e May 8–9, 2025\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOfficial Format:\u003c\/strong\u003e Live Online\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e Two Days\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003ePrimary Specialty:\u003c\/strong\u003e Neurology\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eAdditional Focus:\u003c\/strong\u003e Psychiatry, Women's Health, Obstetrics and Gynecology, Reproductive Psychiatry, Internal Medicine and Primary Care\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eLanguage:\u003c\/strong\u003e English\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOfficial CME:\u003c\/strong\u003e Up to 16.00 AMA PRA Category 1 Credits™\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eEducational Approach:\u003c\/strong\u003e Expert Lectures, Case-Based Discussions, Interactive Panels and Q\u0026amp;A\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eCourse Directors:\u003c\/strong\u003e Mary O'Neal, MD, and Polina Teslyar, MD\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe original Harvard program provided registered participants with access to educational materials and recordings according to the provider's policies.\r\n\r\nPublisher-hosted recordings, official Harvard registration, CME credits, and certificates are not automatically included with separately distributed MedicalAmboss educational files.\r\n\u003ch2\u003eTarget Audience\u003c\/h2\u003e\r\nThe course is intended for healthcare professionals involved in the diagnosis, treatment, and long-term management of neurological and psychiatric conditions affecting women.\r\n\r\nThe target audience includes:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eNeurologists\u003c\/li\u003e\r\n \t\u003cli\u003ePsychiatrists\u003c\/li\u003e\r\n \t\u003cli\u003eObstetricians\u003c\/li\u003e\r\n \t\u003cli\u003eGynecologists\u003c\/li\u003e\r\n \t\u003cli\u003ePrimary Care Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eInternal Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eFamily Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eReproductive Psychiatrists\u003c\/li\u003e\r\n \t\u003cli\u003eWomen's Health Specialists\u003c\/li\u003e\r\n \t\u003cli\u003eEpileptologists\u003c\/li\u003e\r\n \t\u003cli\u003eHeadache Specialists\u003c\/li\u003e\r\n \t\u003cli\u003eNeuropsychiatrists\u003c\/li\u003e\r\n \t\u003cli\u003ePsychologists\u003c\/li\u003e\r\n \t\u003cli\u003eMaternal-Fetal Medicine Specialists\u003c\/li\u003e\r\n \t\u003cli\u003ePhysician Assistants\u003c\/li\u003e\r\n \t\u003cli\u003eNurse Practitioners\u003c\/li\u003e\r\n \t\u003cli\u003eRegistered Nurses\u003c\/li\u003e\r\n \t\u003cli\u003eAdvanced Practice Providers\u003c\/li\u003e\r\n \t\u003cli\u003eMedical Residents\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Fellows\u003c\/li\u003e\r\n \t\u003cli\u003eOther Healthcare Professionals Involved in Women's Neurological and Mental Health\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe program is particularly relevant to clinicians seeking sex-specific approaches to neurological disease, reproductive psychiatric care, and the management of complex medical conditions during hormonal transitions.\r\n\u003ch2\u003eProgram Overview\u003c\/h2\u003e\r\nNeurological and psychiatric disorders may affect women differently due to biological, hormonal, reproductive, and psychosocial factors.\r\n\r\nThroughout life, changes associated with menarche, menstruation, contraception, pregnancy, childbirth, postpartum recovery, and menopause can influence disease presentation, symptom severity, treatment decisions, and clinical outcomes.\r\n\r\nThe \u003cstrong\u003eHarvard Update on Neurology and Psychiatry of Women 2025\u003c\/strong\u003e addresses these challenges through a comprehensive review of women's neurological and mental health.\r\n\r\nThe program covers:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMigraine in Women\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Influences on Headache Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eContraception in Neurological and Psychiatric Disease\u003c\/li\u003e\r\n \t\u003cli\u003eFunctional Neurological Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eAutonomic Disorders in Women\u003c\/li\u003e\r\n \t\u003cli\u003eCare for Transgender and Gender-Diverse People\u003c\/li\u003e\r\n \t\u003cli\u003eSexual Health and Sexual Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003eBipolar Disorder During Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003ePsychosis in Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eTrauma-Informed Care\u003c\/li\u003e\r\n \t\u003cli\u003eNeurological Assessment During Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eCommon Neurological Consultations in Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eEpilepsy and Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eAntiseizure Medication Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eSubstance Use Disorders in Perinatal Patients\u003c\/li\u003e\r\n \t\u003cli\u003ePerinatal Anxiety\u003c\/li\u003e\r\n \t\u003cli\u003ePerinatal Depression\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Mood Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eAlzheimer's Disease in Women\u003c\/li\u003e\r\n \t\u003cli\u003eSex Differences in Cognitive Aging\u003c\/li\u003e\r\n \t\u003cli\u003eSports Neurology\u003c\/li\u003e\r\n \t\u003cli\u003eFemale Athlete Neurological Health\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe curriculum emphasizes interdisciplinary clinical decision-making and the integration of neurological, psychiatric, obstetric, and reproductive considerations into individualized patient management.\r\n\u003ch2\u003eLearning Objectives\u003c\/h2\u003e\r\nAfter completing the original educational activity, participants should be better able to:\r\n\u003col start=\"1\" data-spread=\"true\"\u003e\r\n \t\u003cli\u003eApply sex-specific and hormone-related clinical evidence to the diagnosis and treatment of neurological and psychiatric disorders affecting women.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate treatment strategies throughout different stages of a woman's reproductive and hormonal life cycle.\u003c\/li\u003e\r\n \t\u003cli\u003eAssess the benefits and risks of neurological and psychiatric therapies during pregnancy, postpartum recovery, and other hormonal transitions.\u003c\/li\u003e\r\n \t\u003cli\u003eImplement appropriate clinical guidelines for the treatment of neurological and psychiatric disorders in women.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize the influence of reproductive hormones on migraine, epilepsy, mood disorders, and other neurological conditions.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate contraception options and reproductive planning considerations in women receiving neurological or psychiatric treatment.\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify important neurological complications during pregnancy and determine when specialist assessment is appropriate.\u003c\/li\u003e\r\n \t\u003cli\u003eApply evidence-based approaches to the management of perinatal anxiety, depression, bipolar disorder, and psychosis.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize autonomic and functional neurological disorders in women and consider multidisciplinary treatment strategies.\u003c\/li\u003e\r\n \t\u003cli\u003eReview clinical considerations involving Alzheimer's disease, cognitive aging, sexual health, trauma-informed care, and neurological health in female athletes.\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\nThe first four objectives summarize the official educational goals; the remaining objectives reflect the broader clinical themes included in the published agenda.\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eOfficial Program Topics\u003c\/h1\u003e\r\n\u003ch2\u003eDay 1 – Thursday, May 8, 2025\u003c\/h2\u003e\r\n\u003ch3\u003eSession I – Headache and Neurological Disorders\u003c\/h3\u003e\r\n\u003ch3\u003eMigraine and Women\u003c\/h3\u003e\r\n\u003cstrong\u003e8:00 AM – 8:55 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Carolyn Bernstein, MD\r\n\r\nThis session reviews migraine and its clinical implications for women's neurological health.\r\n\r\nMigraine is an important neurological disorder whose frequency and presentation may be influenced by hormonal fluctuations and reproductive transitions.\r\n\r\nImportant clinical considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMigraine Epidemiology in Women\u003c\/li\u003e\r\n \t\u003cli\u003eSex Differences in Migraine\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Influences on Headache\u003c\/li\u003e\r\n \t\u003cli\u003eMenstrual Migraine\u003c\/li\u003e\r\n \t\u003cli\u003eMigraine During Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eMigraine During the Postpartum Period\u003c\/li\u003e\r\n \t\u003cli\u003eMigraine and Menopause\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eAcute Migraine Treatment\u003c\/li\u003e\r\n \t\u003cli\u003ePreventive Migraine Therapy\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Safety\u003c\/li\u003e\r\n \t\u003cli\u003eIndividualized Treatment Strategies\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session supports evidence-based migraine management while considering reproductive health and hormonal factors.\r\n\u003ch3\u003eContraception in Women with Neurologic and Psychiatric Disorders\u003c\/h3\u003e\r\n\u003cstrong\u003e9:00 AM – 9:55 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Sara Neill, MD\r\n\r\nThis presentation explores contraception and reproductive planning in women with neurological and psychiatric conditions.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eHormonal Contraception\u003c\/li\u003e\r\n \t\u003cli\u003eNon-Hormonal Contraceptive Options\u003c\/li\u003e\r\n \t\u003cli\u003eContraception in Epilepsy\u003c\/li\u003e\r\n \t\u003cli\u003eContraception in Migraine\u003c\/li\u003e\r\n \t\u003cli\u003eContraception in Psychiatric Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eDrug Interactions\u003c\/li\u003e\r\n \t\u003cli\u003eAntiseizure Medications\u003c\/li\u003e\r\n \t\u003cli\u003ePsychiatric Medication Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eReproductive Planning\u003c\/li\u003e\r\n \t\u003cli\u003eRisk-Benefit Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eShared Decision-Making\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe discussion emphasizes coordination between neurology, psychiatry, obstetrics, and reproductive healthcare.\r\n\u003ch3\u003eFunctional Neurological Disorders – A Case-Based Panel Discussion\u003c\/h3\u003e\r\n\u003cstrong\u003e10:00 AM – 10:55 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eBarbara Dworetzky, MD\u003c\/li\u003e\r\n \t\u003cli\u003eNathan Praschan, MD, MPH\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThis interactive panel reviews functional neurological disorders through clinical cases and multidisciplinary discussion.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eFunctional Neurological Disorder\u003c\/li\u003e\r\n \t\u003cli\u003eFunctional Seizures\u003c\/li\u003e\r\n \t\u003cli\u003eNeurological Symptom Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Diagnostic Features\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003ePsychiatric Comorbidities\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Communication\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary Management\u003c\/li\u003e\r\n \t\u003cli\u003eRehabilitation Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eCase-Based Clinical Reasoning\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes structured evaluation and collaborative management of patients with functional neurological symptoms.\r\n\u003ch3\u003eAutonomic Disorders in Women\u003c\/h3\u003e\r\n\u003cstrong\u003e11:00 AM – 11:55 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Aditi Varma-Doyle, MD\r\n\r\nThis presentation examines autonomic nervous system disorders affecting women.\r\n\r\nRelevant areas include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eAutonomic Nervous System Function\u003c\/li\u003e\r\n \t\u003cli\u003eAutonomic Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003eOrthostatic Intolerance\u003c\/li\u003e\r\n \t\u003cli\u003ePostural Orthostatic Tachycardia Syndrome\u003c\/li\u003e\r\n \t\u003cli\u003eSyncope\u003c\/li\u003e\r\n \t\u003cli\u003eAutonomic Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Evaluation\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eSymptom Management\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary Care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe discussion addresses clinical approaches to symptoms involving cardiovascular and neurological autonomic regulation.\r\n\u003ch2\u003eSession II – Women's Mental Health and Sexual Health\u003c\/h2\u003e\r\n\u003ch3\u003eCare for Transgender and Gender Diverse People\u003c\/h3\u003e\r\n\u003cstrong\u003e1:00 PM – 1:55 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Alex Keuroghlian, MD\r\n\r\nThis session reviews principles of inclusive healthcare for transgender and gender-diverse patients.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eGender-Affirming Clinical Care\u003c\/li\u003e\r\n \t\u003cli\u003eMental Health Assessment\u003c\/li\u003e\r\n \t\u003cli\u003ePatient-Centered Communication\u003c\/li\u003e\r\n \t\u003cli\u003eHealthcare Access\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Support\u003c\/li\u003e\r\n \t\u003cli\u003eRespectful Care Practices\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary Collaboration\u003c\/li\u003e\r\n \t\u003cli\u003eIndividualized Treatment Planning\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation emphasizes clinically appropriate and respectful healthcare across neurological and psychiatric settings.\r\n\u003ch3\u003eSexual Health and Treatment of Sexual Dysfunction in Women\u003c\/h3\u003e\r\n\u003cstrong\u003e2:00 PM – 2:55 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Nichola Haddad, MD\r\n\r\nThis session examines female sexual health and the management of sexual dysfunction.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eFemale Sexual Function\u003c\/li\u003e\r\n \t\u003cli\u003eSexual Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003eClinical History\u003c\/li\u003e\r\n \t\u003cli\u003ePsychological Contributors\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Factors\u003c\/li\u003e\r\n \t\u003cli\u003eNeurological Contributors\u003c\/li\u003e\r\n \t\u003cli\u003eMedication-Associated Sexual Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003eRelationship and Psychosocial Factors\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Evaluation\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Approaches\u003c\/li\u003e\r\n \t\u003cli\u003ePatient-Centered Counseling\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation explores the integration of medical, psychiatric, and reproductive considerations in sexual healthcare.\r\n\u003ch2\u003eSession III – Reproductive Psychiatry\u003c\/h2\u003e\r\n\u003ch3\u003eBipolar Disorder and Psychosis in Pregnancy\u003c\/h3\u003e\r\n\u003cstrong\u003e3:00 PM – 3:55 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Amanda Koire, MD, PhD\r\n\r\nThis session reviews the clinical challenges of managing bipolar disorder and psychotic illness during pregnancy.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eBipolar Disorder in Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003ePsychotic Disorders\u003c\/li\u003e\r\n \t\u003cli\u003ePsychiatric Relapse Risk\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Management\u003c\/li\u003e\r\n \t\u003cli\u003eMaternal Mental Health\u003c\/li\u003e\r\n \t\u003cli\u003eFetal Safety Considerations\u003c\/li\u003e\r\n \t\u003cli\u003ePerinatal Psychiatric Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eRisk-Benefit Evaluation\u003c\/li\u003e\r\n \t\u003cli\u003ePostpartum Relapse Prevention\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary Care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe discussion emphasizes individualized management that balances maternal psychiatric stability with reproductive safety.\r\n\u003ch3\u003eTrauma Informed Care\u003c\/h3\u003e\r\n\u003cstrong\u003e4:00 PM – 4:55 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Nomi Levy-Carrick, MD\r\n\r\nThis session reviews trauma-informed approaches to clinical assessment and patient care.\r\n\r\nTopics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePsychological Trauma\u003c\/li\u003e\r\n \t\u003cli\u003eTrauma-Informed Clinical Practice\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Safety\u003c\/li\u003e\r\n \t\u003cli\u003eTherapeutic Communication\u003c\/li\u003e\r\n \t\u003cli\u003eRecognition of Trauma-Related Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eAvoiding Retraumatization\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Trust\u003c\/li\u003e\r\n \t\u003cli\u003eShared Decision-Making\u003c\/li\u003e\r\n \t\u003cli\u003eMental Health Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eIntegrated Care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation highlights the relevance of trauma-informed practice across neurological, psychiatric, and general medical settings.\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eDay 2 – Friday, May 9, 2025\u003c\/h2\u003e\r\n\u003ch2\u003eSession IV – Neurology and Pregnancy\u003c\/h2\u003e\r\n\u003ch3\u003ePregnancy – What the Non-OB Needs to Know\u003c\/h3\u003e\r\n\u003cstrong\u003e8:00 AM – 8:55 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Nicole Smith, MD, MPH\r\n\r\nThis session reviews essential pregnancy-related concepts for clinicians outside obstetrics.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMaternal Physiological Changes\u003c\/li\u003e\r\n \t\u003cli\u003ePregnancy-Related Medical Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Safety\u003c\/li\u003e\r\n \t\u003cli\u003eNeurological and Psychiatric Treatment Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eMaternal Health Monitoring\u003c\/li\u003e\r\n \t\u003cli\u003eRecognition of Pregnancy Complications\u003c\/li\u003e\r\n \t\u003cli\u003eObstetric Collaboration\u003c\/li\u003e\r\n \t\u003cli\u003eSpecialist Referral\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation supports improved coordination between obstetric and non-obstetric clinicians.\r\n\u003ch3\u003eCommon Neurologic Consults in Pregnancy\u003c\/h3\u003e\r\n\u003cstrong\u003e9:00 AM – 9:55 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Mary O'Neal, MD\r\n\r\nThis presentation reviews neurological symptoms and conditions commonly requiring consultation during pregnancy.\r\n\r\nRelevant clinical areas include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eHeadache in Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eSeizures\u003c\/li\u003e\r\n \t\u003cli\u003eNeurological Deficits\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eNeurological Emergencies\u003c\/li\u003e\r\n \t\u003cli\u003eNeuroimaging Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Safety\u003c\/li\u003e\r\n \t\u003cli\u003eMaternal-Fetal Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eNeurology Consultation\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary Management\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes an organized clinical approach to neurological presentations during pregnancy.\r\n\u003ch3\u003eEpilepsy and Pregnancy\u003c\/h3\u003e\r\n\u003cstrong\u003e10:00 AM – 10:55 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Paula Emanuela Voinescu, MD, PhD\r\n\r\nThis session examines the management of epilepsy before, during, and after pregnancy.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eEpilepsy in Women\u003c\/li\u003e\r\n \t\u003cli\u003ePreconception Counseling\u003c\/li\u003e\r\n \t\u003cli\u003eSeizure Control During Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eAntiseizure Medication Selection\u003c\/li\u003e\r\n \t\u003cli\u003eMedication-Associated Fetal Risks\u003c\/li\u003e\r\n \t\u003cli\u003ePharmacokinetic Changes\u003c\/li\u003e\r\n \t\u003cli\u003eTherapeutic Drug Monitoring\u003c\/li\u003e\r\n \t\u003cli\u003eMaternal and Fetal Outcomes\u003c\/li\u003e\r\n \t\u003cli\u003eDelivery Planning\u003c\/li\u003e\r\n \t\u003cli\u003ePostpartum Management\u003c\/li\u003e\r\n \t\u003cli\u003eBreastfeeding Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary Epilepsy Care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation emphasizes balancing effective seizure control with pregnancy-related treatment considerations.\r\n\u003ch2\u003eSession V – Perinatal Psychiatric Disorders\u003c\/h2\u003e\r\n\u003ch3\u003eSubstance Use Disorder in Perinatal Patients\u003c\/h3\u003e\r\n\u003cstrong\u003e11:00 AM – 11:55 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Polina Teslyar, MD\r\n\r\nThis session reviews substance use disorders during pregnancy and the postpartum period.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePerinatal Substance Use\u003c\/li\u003e\r\n \t\u003cli\u003eScreening and Clinical Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eSubstance Use Disorder Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003ePsychiatric Comorbidities\u003c\/li\u003e\r\n \t\u003cli\u003eMaternal Health Risks\u003c\/li\u003e\r\n \t\u003cli\u003eFetal and Neonatal Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence-Based Treatment\u003c\/li\u003e\r\n \t\u003cli\u003eHarm Reduction\u003c\/li\u003e\r\n \t\u003cli\u003eRelapse Prevention\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary Support\u003c\/li\u003e\r\n \t\u003cli\u003ePostpartum Care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation emphasizes supportive and evidence-based care for pregnant and postpartum patients affected by substance use disorders.\r\n\u003ch3\u003ePerinatal Anxiety and Depression\u003c\/h3\u003e\r\n\u003cstrong\u003e1:00 PM – 1:55 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Natalie Feldman, MD\r\n\r\nThis session examines anxiety and depressive disorders during pregnancy and the postpartum period.\r\n\r\nImportant clinical considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePerinatal Depression\u003c\/li\u003e\r\n \t\u003cli\u003ePostpartum Depression\u003c\/li\u003e\r\n \t\u003cli\u003ePerinatal Anxiety\u003c\/li\u003e\r\n \t\u003cli\u003eMental Health Screening\u003c\/li\u003e\r\n \t\u003cli\u003eRisk Factors\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003ePsychotherapy\u003c\/li\u003e\r\n \t\u003cli\u003ePharmacological Treatment\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Safety\u003c\/li\u003e\r\n \t\u003cli\u003eMaternal and Infant Wellbeing\u003c\/li\u003e\r\n \t\u003cli\u003ePostpartum Follow-Up\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe discussion emphasizes the importance of early recognition, individualized treatment, and continued psychiatric support.\r\n\u003ch3\u003eHormonally Mediated Mood Issues Across the Life Span\u003c\/h3\u003e\r\n\u003cstrong\u003e2:00 PM – 2:55 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Margo Nathan, MD\r\n\r\nThis session reviews the relationship between reproductive hormones and mood symptoms across different stages of life.\r\n\r\nRelevant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eHormonal Influences on Mood\u003c\/li\u003e\r\n \t\u003cli\u003eMenstrual Cycle-Related Mood Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003ePremenstrual Dysphoric Disorder\u003c\/li\u003e\r\n \t\u003cli\u003ePregnancy-Associated Mood Changes\u003c\/li\u003e\r\n \t\u003cli\u003ePostpartum Mood Disorders\u003c\/li\u003e\r\n \t\u003cli\u003ePerimenopause\u003c\/li\u003e\r\n \t\u003cli\u003eMenopause\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Transitions\u003c\/li\u003e\r\n \t\u003cli\u003eMood Disorder Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eTreatment Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eLongitudinal Psychiatric Care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation examines the relevance of reproductive endocrine changes to psychiatric symptoms and treatment planning.\r\n\u003ch2\u003eSession VI – Cognitive Health and Sports Neurology\u003c\/h2\u003e\r\n\u003ch3\u003eAlzheimer's Disease in Women\u003c\/h3\u003e\r\n\u003cstrong\u003e3:00 PM – 3:55 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Gillian Coughlan, PhD\r\n\r\nThis session examines Alzheimer's disease and its particular relevance to women's cognitive health.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eAlzheimer's Disease\u003c\/li\u003e\r\n \t\u003cli\u003eCognitive Aging\u003c\/li\u003e\r\n \t\u003cli\u003eSex Differences in Dementia\u003c\/li\u003e\r\n \t\u003cli\u003eRisk Factors\u003c\/li\u003e\r\n \t\u003cli\u003eCognitive Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal and Biological Influences\u003c\/li\u003e\r\n \t\u003cli\u003eMemory Impairment\u003c\/li\u003e\r\n \t\u003cli\u003eEmerging Research\u003c\/li\u003e\r\n \t\u003cli\u003eDisease Recognition\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Management Considerations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation provides an educational perspective on cognitive decline and Alzheimer's disease in women.\r\n\u003ch3\u003eSports Neurology – Is It a Man's World?\u003c\/h3\u003e\r\n\u003cstrong\u003e4:00 PM – 4:55 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Claus Reinsberger, MD, PhD\r\n\r\nThis session explores sex-specific considerations in sports neurology.\r\n\r\nImportant areas include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eFemale Athletes\u003c\/li\u003e\r\n \t\u003cli\u003eSex Differences in Neurological Health\u003c\/li\u003e\r\n \t\u003cli\u003eSports-Related Concussion\u003c\/li\u003e\r\n \t\u003cli\u003eHead Injury Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eNeurological Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eAthletic Participation\u003c\/li\u003e\r\n \t\u003cli\u003eInjury Prevention\u003c\/li\u003e\r\n \t\u003cli\u003eReturn-to-Play Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eResearch Gaps\u003c\/li\u003e\r\n \t\u003cli\u003eWomen's Sports Neurology\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation examines why sex-specific research and clinical assessment are important in sports-related neurological care.\r\n\u003ch3\u003eClosing Remarks\u003c\/h3\u003e\r\n\u003cstrong\u003e4:55 PM – 5:00 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Mary O'Neal, MD\r\n\r\nThe course concludes with questions and answers and closing remarks.\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eMajor Topics Covered\u003c\/h2\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eHarvard Update on Neurology and Psychiatry of Women 2025\u003c\/li\u003e\r\n \t\u003cli\u003eWomen's Neurology\u003c\/li\u003e\r\n \t\u003cli\u003eWomen's Psychiatry\u003c\/li\u003e\r\n \t\u003cli\u003eReproductive Psychiatry\u003c\/li\u003e\r\n \t\u003cli\u003eWomen's Mental Health\u003c\/li\u003e\r\n \t\u003cli\u003eSex Differences in Neurological Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Influences on Neurological Disease\u003c\/li\u003e\r\n \t\u003cli\u003eMigraine in Women\u003c\/li\u003e\r\n \t\u003cli\u003eMenstrual Migraine\u003c\/li\u003e\r\n \t\u003cli\u003eMigraine During Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eContraception and Neurological Disease\u003c\/li\u003e\r\n \t\u003cli\u003eContraception and Psychiatric Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eFunctional Neurological Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eFunctional Seizures\u003c\/li\u003e\r\n \t\u003cli\u003eAutonomic Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003eOrthostatic Intolerance\u003c\/li\u003e\r\n \t\u003cli\u003ePostural Orthostatic Tachycardia Syndrome\u003c\/li\u003e\r\n \t\u003cli\u003eTransgender and Gender-Diverse Healthcare\u003c\/li\u003e\r\n \t\u003cli\u003eFemale Sexual Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003eSexual Health\u003c\/li\u003e\r\n \t\u003cli\u003eBipolar Disorder in Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003ePsychosis During Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eTrauma-Informed Care\u003c\/li\u003e\r\n \t\u003cli\u003eNeurological Disorders in Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eEpilepsy and Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eAntiseizure Medication Management\u003c\/li\u003e\r\n \t\u003cli\u003eMaternal-Fetal Neurology\u003c\/li\u003e\r\n \t\u003cli\u003ePerinatal Substance Use Disorder\u003c\/li\u003e\r\n \t\u003cli\u003ePerinatal Anxiety\u003c\/li\u003e\r\n \t\u003cli\u003ePerinatal Depression\u003c\/li\u003e\r\n \t\u003cli\u003ePostpartum Depression\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Mood Disorders\u003c\/li\u003e\r\n \t\u003cli\u003ePremenstrual Dysphoric Disorder\u003c\/li\u003e\r\n \t\u003cli\u003eMenopause and Mental Health\u003c\/li\u003e\r\n \t\u003cli\u003eAlzheimer's Disease in Women\u003c\/li\u003e\r\n \t\u003cli\u003eCognitive Aging\u003c\/li\u003e\r\n \t\u003cli\u003eSports Neurology\u003c\/li\u003e\r\n \t\u003cli\u003eConcussion in Female Athletes\u003c\/li\u003e\r\n \t\u003cli\u003eSex-Specific Treatment\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary Women's Healthcare\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eMigraine and Hormonal Influences\u003c\/h2\u003e\r\nMigraine is a common neurological disorder that can be influenced by reproductive hormonal changes.\r\n\r\nFor some patients, migraine frequency or severity may vary across menstruation, pregnancy, postpartum recovery, and menopause.\r\n\r\nImportant clinical considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eHormonal Triggers\u003c\/li\u003e\r\n \t\u003cli\u003eMenstrual Migraine\u003c\/li\u003e\r\n \t\u003cli\u003ePregnancy-Related Migraine\u003c\/li\u003e\r\n \t\u003cli\u003eMigraine With Aura\u003c\/li\u003e\r\n \t\u003cli\u003eContraceptive Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eAcute Migraine Treatment\u003c\/li\u003e\r\n \t\u003cli\u003ePreventive Therapy\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Safety\u003c\/li\u003e\r\n \t\u003cli\u003eIndividualized Clinical Management\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe course reviews migraine from the perspective of women's neurological and reproductive health.\r\n\u003ch2\u003eEpilepsy and Reproductive Health\u003c\/h2\u003e\r\nEpilepsy management in women requires careful attention to contraception, pregnancy planning, medication safety, and changes in antiseizure drug concentrations.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePreconception Counseling\u003c\/li\u003e\r\n \t\u003cli\u003eAntiseizure Medication Selection\u003c\/li\u003e\r\n \t\u003cli\u003eDrug Interactions\u003c\/li\u003e\r\n \t\u003cli\u003ePregnancy-Related Pharmacokinetic Changes\u003c\/li\u003e\r\n \t\u003cli\u003eSeizure Control\u003c\/li\u003e\r\n \t\u003cli\u003eFetal Risk Considerations\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Monitoring\u003c\/li\u003e\r\n \t\u003cli\u003ePostpartum Management\u003c\/li\u003e\r\n \t\u003cli\u003eBreastfeeding\u003c\/li\u003e\r\n \t\u003cli\u003eNeurology-Obstetrics Collaboration\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe educational curriculum supports informed clinical decision-making throughout reproductive transitions.\r\n\u003ch2\u003ePregnancy and Perinatal Psychiatry\u003c\/h2\u003e\r\nPregnancy and the postpartum period are associated with physiological, hormonal, and psychosocial changes that can affect mental health.\r\n\r\nThe course addresses important psychiatric conditions, including:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eBipolar Disorder\u003c\/li\u003e\r\n \t\u003cli\u003ePsychosis\u003c\/li\u003e\r\n \t\u003cli\u003ePerinatal Depression\u003c\/li\u003e\r\n \t\u003cli\u003ePostpartum Depression\u003c\/li\u003e\r\n \t\u003cli\u003ePerinatal Anxiety\u003c\/li\u003e\r\n \t\u003cli\u003eSubstance Use Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Mood Changes\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThese presentations emphasize timely diagnosis, individualized treatment, risk-benefit assessment, and coordination between psychiatric and obstetric teams.\r\n\u003ch2\u003eHormonal Transitions and Mental Health\u003c\/h2\u003e\r\nReproductive hormones may influence mood and psychiatric symptoms throughout life.\r\n\r\nClinically important transitions include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMenarche\u003c\/li\u003e\r\n \t\u003cli\u003eMenstrual Cycles\u003c\/li\u003e\r\n \t\u003cli\u003ePregnancy\u003c\/li\u003e\r\n \t\u003cli\u003ePostpartum Recovery\u003c\/li\u003e\r\n \t\u003cli\u003ePerimenopause\u003c\/li\u003e\r\n \t\u003cli\u003eMenopause\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe curriculum examines hormonal mood symptoms and their implications for clinical evaluation and psychiatric treatment.\r\n\u003ch2\u003eFunctional and Autonomic Neurological Disorders\u003c\/h2\u003e\r\nFunctional neurological disorders and autonomic conditions may create challenging diagnostic presentations.\r\n\r\nThe course includes dedicated sessions on these disorders.\r\n\r\nRelevant clinical themes include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eFunctional Neurological Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eFunctional Seizures\u003c\/li\u003e\r\n \t\u003cli\u003eAutonomic Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003eOrthostatic Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003ePatient Communication\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary Treatment\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThese topics reinforce the importance of careful neurological assessment and coordinated clinical care.\r\n\u003ch2\u003eWomen's Cognitive Health and Alzheimer's Disease\u003c\/h2\u003e\r\nWomen represent an important population in research and clinical care related to Alzheimer's disease and cognitive aging.\r\n\r\nThe curriculum examines:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCognitive Decline\u003c\/li\u003e\r\n \t\u003cli\u003eAlzheimer's Disease\u003c\/li\u003e\r\n \t\u003cli\u003eSex-Related Risk Factors\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Influences\u003c\/li\u003e\r\n \t\u003cli\u003eCognitive Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eEmerging Research\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Recognition\u003c\/li\u003e\r\n \t\u003cli\u003eManagement Considerations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session provides an opportunity to review neurological research relevant to women's cognitive health.\r\n\u003ch2\u003eSexual Health and Trauma-Informed Care\u003c\/h2\u003e\r\nSexual dysfunction and psychological trauma may influence overall health, quality of life, and clinical interactions.\r\n\r\nThe course examines:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eSexual Function\u003c\/li\u003e\r\n \t\u003cli\u003eFemale Sexual Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003ePsychological Contributors\u003c\/li\u003e\r\n \t\u003cli\u003eMedication Effects\u003c\/li\u003e\r\n \t\u003cli\u003eReproductive Factors\u003c\/li\u003e\r\n \t\u003cli\u003eTrauma-Related Symptoms\u003c\/li\u003e\r\n \t\u003cli\u003ePatient-Centered Communication\u003c\/li\u003e\r\n \t\u003cli\u003eRespectful Clinical Care\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary Support\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentations emphasize sensitive, individualized, and evidence-informed clinical approaches.\r\n\u003ch2\u003eEvidence-Based and Multidisciplinary Women's Healthcare\u003c\/h2\u003e\r\nWomen with complex neurological or psychiatric disorders may require coordinated care involving multiple medical specialties.\r\n\r\nHealthcare teams may include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eNeurologists\u003c\/li\u003e\r\n \t\u003cli\u003ePsychiatrists\u003c\/li\u003e\r\n \t\u003cli\u003eObstetricians\u003c\/li\u003e\r\n \t\u003cli\u003eGynecologists\u003c\/li\u003e\r\n \t\u003cli\u003ePrimary Care Physicians\u003c\/li\u003e\r\n \t\u003cli\u003eReproductive Health Specialists\u003c\/li\u003e\r\n \t\u003cli\u003ePsychologists\u003c\/li\u003e\r\n \t\u003cli\u003eNurse Practitioners\u003c\/li\u003e\r\n \t\u003cli\u003ePhysician Assistants\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe program emphasizes the integration of current clinical evidence with individual patient needs, reproductive goals, hormonal changes, and treatment safety.\r\n\u003ch2\u003eCourse Leadership\u003c\/h2\u003e\r\n\u003ch3\u003eMary O'Neal, MD\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eChief of General Neurology, Brigham and Women's Hospital\u003c\/li\u003e\r\n \t\u003cli\u003eDirector, Women's Neurology Program, Brigham and Women's Hospital\u003c\/li\u003e\r\n \t\u003cli\u003eHarvard Medical School Faculty\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003ePolina Teslyar, MD\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eDirector of Reproductive Psychiatry Consultation\u003c\/li\u003e\r\n \t\u003cli\u003eDivision of Women's Mental Health and Medical Psychiatry\u003c\/li\u003e\r\n \t\u003cli\u003eBrigham and Women's Hospital\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe course includes faculty specializing in neurology, psychiatry, reproductive healthcare, obstetrics, autonomic disorders, epilepsy, cognitive neurology, and women's mental health.\r\n\u003ch2\u003eContinuing Medical Education\u003c\/h2\u003e\r\nHarvard Medical School designated the original 2025 live educational activity for a maximum of:\r\n\r\n\u003cstrong\u003e16.00 AMA PRA Category 1 Credits™\u003c\/strong\u003e\r\n\r\nHarvard Medical School is jointly accredited by ACCME, ACPE, and ANCC to provide continuing education for healthcare professionals.\r\n\u003ch3\u003eImportant CME Notice\u003c\/h3\u003e\r\nThe credit designation applies to eligible participation in the official Harvard educational activity according to the provider's completion and evaluation requirements.\r\n\r\nPurchasing separately distributed educational materials from MedicalAmboss does not provide:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eHarvard Medical School CME Credits\u003c\/li\u003e\r\n \t\u003cli\u003eOfficial Completion Certificates\u003c\/li\u003e\r\n \t\u003cli\u003eHarvard Course Registration\u003c\/li\u003e\r\n \t\u003cli\u003eLive Online Attendance\u003c\/li\u003e\r\n \t\u003cli\u003eOfficial Harvard Account Access\u003c\/li\u003e\r\n \t\u003cli\u003ePublisher Streaming Access\u003c\/li\u003e\r\n \t\u003cli\u003ePublisher-Hosted Recordings Unless Explicitly Listed\u003c\/li\u003e\r\n \t\u003cli\u003eOther Publisher Educational Benefits\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eWhy This Course Is Relevant\u003c\/h2\u003e\r\nThe \u003cstrong\u003eHarvard Update on Neurology and Psychiatry of Women 2025\u003c\/strong\u003e addresses important clinical challenges encountered by healthcare professionals caring for women with neurological and psychiatric disorders.\r\n\r\nThese conditions may be influenced by reproductive hormones, pregnancy, postpartum changes, menopause, medication effects, and sex-specific biological factors.\r\n\r\nThe course provides a multidisciplinary educational review of:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMigraine and Hormonal Headache Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eEpilepsy During Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eFunctional Neurological Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eAutonomic Dysfunction\u003c\/li\u003e\r\n \t\u003cli\u003ePerinatal Psychiatric Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eBipolar Disorder and Psychosis in Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eAnxiety and Depression\u003c\/li\u003e\r\n \t\u003cli\u003eSubstance Use Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eHormonal Mood Changes\u003c\/li\u003e\r\n \t\u003cli\u003eAlzheimer's Disease\u003c\/li\u003e\r\n \t\u003cli\u003eSexual Health\u003c\/li\u003e\r\n \t\u003cli\u003eTrauma-Informed Care\u003c\/li\u003e\r\n \t\u003cli\u003eSports Neurology\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe combination of neurological, psychiatric, obstetric, and reproductive perspectives makes the program especially relevant to neurologists, psychiatrists, obstetricians, gynecologists, primary care physicians, and other healthcare professionals interested in women's health.\r\n\r\nIts emphasis on evidence-based clinical management, treatment safety, and individualized healthcare supports continuing professional education in women's neurological and psychiatric medicine.\r\n\u003ch2\u003eOfficial Program Reference and MedicalAmboss Purchase Scope\u003c\/h2\u003e\r\n\u003cstrong\u003eOfficial Harvard Medical School Course:\u003c\/strong\u003e\r\n\r\n\u003ca href=\"https:\/\/cmecatalog.hms.harvard.edu\/update-neurology-psychiatry-women\" data-rich-text-autolink=\"\"\u003ehttps:\/\/cmecatalog.hms.harvard.edu\/update-neurology-psychiatry-women\u003c\/a\u003e\r\n\r\n\u003cstrong\u003eOfficial 2025 Course Agenda:\u003c\/strong\u003e\r\n\r\n\u003ca href=\"https:\/\/cmecatalog.hms.harvard.edu\/update-neurology-psychiatry-women\/agenda\" data-rich-text-autolink=\"\"\u003ehttps:\/\/cmecatalog.hms.harvard.edu\/update-neurology-psychiatry-women\/agenda\u003c\/a\u003e\r\n\r\nThe official agenda describes the original May 8–9, 2025 educational program, including session topics, faculty, and schedule.\r\n\r\nIt does not establish the exact inventory of digital files available through a separately distributed MedicalAmboss listing.\r\n\r\n\u003cstrong\u003eMedicalAmboss File Scope:\u003c\/strong\u003e This listing describes the educational subject matter for reference. Provider registration, live attendance, streaming-platform access, CME or other credit, certificates, memberships, apps, accounts, and publisher-hosted extras are not included unless explicitly listed as store files.\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eShort Description\u003c\/h2\u003e\r\n\u0026lt;div style=\"border:2px solid #1677b8;border-radius:10px;padding:16px;background:#f7fbfe;\"\u0026gt;\r\n\r\n\u003cstrong\u003eHarvard Update on Neurology and Psychiatry of Women 2025\u003c\/strong\u003e provides a comprehensive, evidence-based review of women's neurological and psychiatric health, focusing on sex differences, hormonal transitions, pregnancy, postpartum care, and menopause.\r\n\r\nThe May 8–9, 2025 Harvard Medical School program covers migraine, epilepsy, contraception, functional neurological disorders, autonomic dysfunction, perinatal depression and anxiety, bipolar disorder, pregnancy-related psychosis, hormonal mood disorders, Alzheimer's disease, sexual health, trauma-informed care, and sports neurology.\r\n\u003ch3\u003eTopics\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eAlzheimer’s Disease in Women, Harvard Medical School course ‘Update on Neurology and Psychiatry of Women’\u003c\/li\u003e\r\n \t\u003cli\u003eAUTONOMIC DISORDERS IN WOMEN\u003c\/li\u003e\r\n \t\u003cli\u003eBipolar disorder and psychosis in pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eCare for Transgender and Gender Diverse Patients\u003c\/li\u003e\r\n \t\u003cli\u003eCommon Neurologic Consults in Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eContraception for Women with Neurologic and Psychiatric Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eEpilepsy in Pregnancy\u003c\/li\u003e\r\n \t\u003cli\u003eFunctional Neurological Disorder\u003c\/li\u003e\r\n \t\u003cli\u003eHeadaches and Hormones\u003c\/li\u003e\r\n \t\u003cli\u003eManagement of Substance Use Disorders in Perinatal Patients\u003c\/li\u003e\r\n \t\u003cli\u003eMood and Anxiety Disorders in Pregnancy and Postpartum\u003c\/li\u003e\r\n \t\u003cli\u003ePregnancy- What the non-Ob needs to know\u003c\/li\u003e\r\n \t\u003cli\u003eSEXUAL HEALTH \u0026amp; TREATMENT OF SEXUAL DYSFUNCTION IN WOMEN\u003c\/li\u003e\r\n \t\u003cli\u003eSports Neurology – is it a man’s world.\u003c\/li\u003e\r\n \t\u003cli\u003eTrauma Informed Care- Implications for Women’s Mental Health\u003c\/li\u003e\r\n \t\u003cli\u003eUpdate on Neurology and Psychiatry of Women- Day 1\u003c\/li\u003e\r\n \t\u003cli\u003eUpdate on Neurology and Psychiatry of Women- Day 2\u003c\/li\u003e\r\n \t\u003cli\u003eWomen’s Mood Disorders Across the Lifespan\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n \r\n\r\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e","brand":"Amboss","offers":[{"title":"Default Title","offer_id":67967780880538,"sku":"MED-AMB10534","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/macs-0efe51bcb5-50424-50433-ffe1deeb794e453a674d.jpg?v=1793059361","url":"https:\/\/ambosscourse.com\/products\/wc-0efe51bcb5f34c14-50424","provider":"Amboss","version":"1.0","type":"link"}